Literature DB >> 31053467

The Efficacy and Safety of Inpatient Rehabilitation Compared With Home Discharge After Hip or Knee Arthroplasty: A Meta-Analysis and Systematic Review.

James Randolph Onggo1, Jason Derry Onggo1, Richard De Steiger2, Raphael Hau3.   

Abstract

BACKGROUND: Total hip and knee arthroplasties (THKAs) are successful procedures in managing end-stage arthritis when nonoperative treatments fail. The immediate postoperative period is an important time for the body to recuperate and rehabilitate. Studies have shown that early intensive rehabilitation can enhance recovery. Rehabilitation can be provided as inpatient rehabilitation (IR) or discharge with home rehabilitation. These options have been studied, but literature on the efficacy and safety of IR compared to home discharge is scarce, and evidence is not well established. This meta-analysis aims to compare the efficacy and safety of IR to home discharge with rehabilitation after THKA.
METHODS: A multidatabase search was performed according to PRISMA guidelines. Data from studies assessing the efficacy and safety of IR and home as discharge destinations after THKA were extracted and analyzed.
RESULTS: Fifteen studies were included, consisting of 37,411 IR patients and 172,219 home discharge patients. These studies had heterogeneous reporting methods, with some conflicting results. There was no clinically significant difference in clinical outcomes between the groups. Readmission was nearly 5 times (odds ratio = 4.87, 95% confidence interval = 3.24-7.33, P < .001) and periprosthetic complications nearly 3 times (odds ratio = 2.82, 95% confidence interval: 1.54-5.24, P < .001) higher in IR patients than those discharged home after THKA.
CONCLUSION: Although IR is associated with higher risks of complications and readmissions, this may be because of patient selection bias in the clinical setting. Following THKA, it is safe to discharge patients to home with rehabilitation whenever possible. EVIDENCE LEVEL: Level II, Meta-analysis of heterogeneous studies.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  arthroplasty; complications; hip; inpatient rehabilitation; knee; outcomes

Mesh:

Year:  2019        PMID: 31053467     DOI: 10.1016/j.arth.2019.04.001

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  6 in total

1.  INFLUENCE OF FEMORAL OFFSET ON FUNCTIONAL CAPACITY OF PATIENTS WITH TOTAL HIP ARTHROPLASTY.

Authors:  Bruna de Moraes Lopes; Leandro de Freitas Spinelli; Carlos Roberto Galia; Carlos Roberto Schwartsmann; Marcelo Faria Silva
Journal:  Acta Ortop Bras       Date:  2022-05-23       Impact factor: 0.683

2.  Utilisation of inpatient rehabilitation following elective total knee or hip replacements in private hospital setting declined during the COVID-19 pandemic.

Authors:  Jason A Wallis; Kirby Young; Shay Zayontz; Phillipa Risbey; Rachelle Buchbinder
Journal:  Intern Med J       Date:  2021-03       Impact factor: 2.048

3.  CORR Insights®: Preoperative Activities of Daily Living Dependency Is Associated With Higher 30-Day Readmission Risk for Older Adults After Total Joint Arthroplasty.

Authors:  Matthew L Webb
Journal:  Clin Orthop Relat Res       Date:  2020-02       Impact factor: 4.755

4.  Comparison of Highly Intensive Home-Based Post-acute Care to Inpatient Program for Patients With Fragility Fractures After Surgery.

Authors:  Min-Chang Lee; Lin-Chung Woung; Jau-Yih Tsauo; Shih-Liang Shih; Hung-Ming Chen; Da-Chen Chu; Sheng-Jean Huang
Journal:  Geriatr Orthop Surg Rehabil       Date:  2022-04-23

5.  Exploring patient acceptability of a short-stay care pathway in hospital post arthroplasty: A theory-informed qualitative study.

Authors:  Cassie E McDonald; Camille Paynter; Jill J Francis; Daevyd Rodda; Supreet Bajwa; Dwane Jackson; David Story
Journal:  Health Expect       Date:  2022-06-30       Impact factor: 3.318

Review 6.  Protective Effect of Resveratrol on Knee Osteoarthritis and its Molecular Mechanisms: A Recent Review in Preclinical and Clinical Trials.

Authors:  Shenglei Yang; Mingli Sun; Xinan Zhang
Journal:  Front Pharmacol       Date:  2022-07-25       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.